Product Details
| Alternative Name: | CNX |
| |
| MW: | ~74kDa |
| |
| Source: | Produced in E. coli. |
| |
| UniProt ID: | P27824 |
| |
| Formulation: | Liquid. In TRIS containing sodium chloride, 5% glycerol, and 5mM calcium chloride. |
| |
| Purity: | ≥85% (SDS-PAGE; Western blot) (full length protein) |
| |
| Purity Detail: | Purified by multi-step chromatography. |
| |
| Applications: | WB
|
| |
| Application Notes: | Western blot control. |
| |
| Shipping: | Dry Ice |
| |
| Long Term Storage: | -80°C |
| |
| Scientific Background: | Calnexin (CNX), an abundant ~90 kDa molecular chaperone, is a resident type I transmembrane protein of the endoplasmic reticulum (ER) (ref.1,2). A majority of the calnexin protein resides in the luminal portion of the ER, and is the membrane-bound paralog of the soluble ER protein Calreticulin. In mammalian cells, calnexin and calreticulin (CRT) are lectins that play key roles in glycoprotein folding within the ER, specifically binding oligosaccharide intermediates that contain a single terminal GlcManGlcNAc residue. Calnexin associates with newly synthesized, incompletely folded monomeric glycoproteins as well as numerous oligomeric protein complexes, including |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Western Blot analysis of Calnexin lumenal domain (Prod. No. ADI-SPP-865) probed with 1:1,000 dilution of Prod. No. ADI-SPA-865. Lane 1: MW marker, Lane 2: 50ng; Lane 3: 100ng
SDS-PAGE analysis of Calnexin lumenal domain (Prod. No. ADI-SPP-865) stained with Coomassie. Lane 1: MWM, Lane 2: 0.5µg; Lane 3: 1µg; Lane 4: 2µg; Lane 5: 5µg
Please mouse over
Product Literature References
Hsa-miR-30d, secreted by the human endometrium, is taken up by the pre-implantation embryo and might modify its transcriptome: F. Vilella, et al.; Development.
142, 3210 (2015),
Application(s): Western Blot,
Abstract;
Full Text
Related Products
